Paper26258564
Implementation and Operational Research: Cost-Effectiveness of Antiretroviral Therapy and Isoniazid Prophylaxis to Reduce Tuberculosis and Death in People Living With HIV in Botswana.
Smith T and 4 others. J Acquir Immune Defic Syndr, 2015. Cited by 7 papers, by iCite.
Cite this record
ConductScience Library. Implementation and Operational Research: Cost-Effectiveness of Antiretroviral Therapy and Isoniazid Prophylaxis to Reduce Tuberculosis and Death in People Living With HIV in Botswana. Papers, record 26258564. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26258564
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Implementation and Operational Research: Cost-Effectiveness of Antiretroviral Therapy and Isoniazid Prophylaxis to Reduce Tuberculosis and Death in People Living With HIV in Botswana.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-HIV Agents | Major topic |
| HIV Infections | Major topic |
| Isoniazid | Major topic |
| Botswana | |
| Cost-Benefit Analysis | |
| Humans | |
| Tuberculosis |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| CC999999 | Intramural CDC HHS | United States | PubMed |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT03302299 | Alcohol Drinkers' Exposure to Preventive Therapy for TB (ADEPTT) | Background |
Source ClinicalTrials.gov
References54
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 16343345 | Cost, affordability and cost-effectiveness of strategies to control tuberculosis in countries with high HIV prevalence. | BMC Public Health | 2005 | https://conductscience.org/library/papers/16343345 | PubMed |
| 2 | 19105878 | A simple screening tool for active tuberculosis in HIV-infected adults receiving antiretroviral treatment in Uganda. | Int J Tuberc Lung Dis | 2009 | https://conductscience.org/library/papers/19105878 | PubMed |
| 3 | 11216930 | Long-term effect of preventive therapy for tuberculosis in a cohort of HIV-infected Zambian adults. | AIDS | 2001 | https://conductscience.org/library/papers/11216930 | PubMed |
| 4 | 16776453 | Cost-effectiveness of including tuberculin skin testing in an IPT program for HIV-infected persons in Uganda. | Int J Tuberc Lung Dis | 2006 | https://conductscience.org/library/papers/16776453 | PubMed |
| 5 | 20091503 | Treatment of latent tuberculosis infection in HIV infected persons. | Cochrane Database Syst Rev | 2010 | https://conductscience.org/library/papers/20091503 | PubMed |
| 6 | 10611855 | Preventive therapy against tuberculosis in people living with HIV. | Wkly Epidemiol Rec | 1999 | https://conductscience.org/library/papers/10611855 | PubMed |
| 7 | 19461502 | Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa. | AIDS | 2009 | https://conductscience.org/library/papers/19461502 | PubMed |
| 8 | 21148723 | Costs and consequences of additional chest x-ray in a tuberculosis prevention program in Botswana. | Am J Respir Crit Care Med | 2011 | https://conductscience.org/library/papers/21148723 | PubMed |
| 9 | 20974976 | Antiretroviral therapy for tuberculosis control in nine African countries. | Proc Natl Acad Sci U S A | 2010 | https://conductscience.org/library/papers/20974976 | PubMed |
| 10 | 22460971 | Impact of antiretroviral therapy on tuberculosis incidence among HIV-positive patients in high-income countries. | Clin Infect Dis | 2012 | https://conductscience.org/library/papers/22460971 | PubMed |
| 11 | 12126821 | Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. | Lancet | 2002 | https://conductscience.org/library/papers/12126821 | PubMed |
| 12 | 16810113 | CD4 decline and incidence of opportunistic infections in Cape Town, South Africa: implications for prophylaxis and treatment. | J Acquir Immune Defic Syndr | 2006 | https://conductscience.org/library/papers/16810113 | PubMed |
| 13 | 20003694 | Tuberculosis in asymptomatic HIV-infected adults with abnormal chest radiographs screened for tuberculosis prevention. | Int J Tuberc Lung Dis | 2010 | https://conductscience.org/library/papers/20003694 | PubMed |
| 14 | 19223783 | Intensified tuberculosis case finding among HIV-Infected persons from a voluntary counseling and testing center in Addis Ababa, Ethiopia. | J Acquir Immune Defic Syndr | 2009 | https://conductscience.org/library/papers/19223783 | PubMed |
| 15 | 11722271 | Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy. | JAMA | 2001 | https://conductscience.org/library/papers/11722271 | PubMed |
| 16 | 21209794 | Scaling up the 2010 World Health Organization HIV Treatment Guidelines in resource-limited settings: a model-based analysis. | PLoS Med | 2010 | https://conductscience.org/library/papers/21209794 | PubMed |
| 17 | 12086758 | Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study. | Lancet | 2002 | https://conductscience.org/library/papers/12086758 | PubMed |
| 18 | 17516410 | Clinical, immunological, and epidemiological importance of antituberculosis T cell responses in HIV-infected Africans. | Clin Infect Dis | 2007 | https://conductscience.org/library/papers/17516410 | PubMed |
| 19 | 12693883 | Survival benefit of initiating antiretroviral therapy in HIV-infected persons in different CD4+ cell strata. | Ann Intern Med | 2003 | https://conductscience.org/library/papers/12693883 | PubMed |
| 20 | 17786198 | Impact of antiretroviral therapy on the incidence of tuberculosis: the Brazilian experience, 1995-2001. | PLoS One | 2007 | https://conductscience.org/library/papers/17786198 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 34520463 | Economic and modeling evidence for tuberculosis preventive therapy among people living with HIV: A systematic review and meta-analysis. | PLoS Med | 2021 | https://conductscience.org/library/papers/34520463 | PubMed |
| 32363543 | A Systematic Review of Methodological Variation in Healthcare Provider Perspective Tuberculosis Costing Papers Conducted in Low- and Middle-Income Settings, Using An Intervention-Standardised Unit Cost Typology. | Pharmacoeconomics | 2020 | https://conductscience.org/library/papers/32363543 | PubMed |
| 29862942 | TB preventive therapy for people living with HIV: key considerations for scale-up in resource-limited settings. | Int J Tuberc Lung Dis | 2018 | https://conductscience.org/library/papers/29862942 | PubMed |
| 29187783 | The effect of micronutrient supplementation on active TB incidence early in HIV infection in Botswana. | Nutr Diet Suppl | 2017 | https://conductscience.org/library/papers/29187783 | PubMed |
| 28724374 | Cost-Effectiveness of isoniazid preventive therapy among HIV-infected patients clinicaly screened for latent tuberculosis infection in Dar es Salaam, Tanzania: A prospective Cohort study. | BMC Public Health | 2017 | https://conductscience.org/library/papers/28724374 | PubMed |
| 27708678 | Current trends and intricacies in the management of HIV-associated pulmonary tuberculosis. | AIDS Res Ther | 2016 | https://conductscience.org/library/papers/27708678 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| CD4 | 920 | PubTator's text mining | https://conductscience.org/library/genes/920 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/26258564
GET https://conductscience.org/api/papers/v1/26258564/references?page=2